Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Summary

This study will assess the efficacy and safety of GI198745 0.5mg given once daily for 52 weeks to Benign Prostatic Hyperplasia (BPH) patients.

Timeline

Start

2006-02-17

Primary completion

2007-12-01

Completion

2007-12-06

Publications

• Background Tsukamoto T, Endo Y, Narita M. Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia. Int J Urol. 2009 Sep;16(9):745-50. doi: 10.1111/j.1442-2042.2009.02357.x. Epub 2009 Aug 5.

Drugs

Indications